The Role of Hyperglycemia, Insulin Resistance, and Blood Pressure in Diabetes-Associated Differences in Cognitive Performance-The Maastricht Study

被引:59
作者
Geijselaers, Stefan L. C. [1 ,2 ,3 ]
Sep, Simone J. S. [1 ,2 ]
Claessens, Danny [1 ]
Schram, Miranda T. [1 ,2 ]
van Boxtel, Martin P. J. [4 ,5 ]
Henry, Ronald M. A. [1 ,2 ]
Verhey, Frans R. J. [4 ,5 ]
Kroon, Abraham A. [1 ,2 ]
Dagnelie, Pieter C. [2 ,6 ,7 ]
Schalkwijk, Casper G. [1 ,2 ]
van der Kallen, Carla J. H. [1 ,2 ]
Biessels, Geert Jan [3 ]
Stehouwer, Coen D. A. [1 ,2 ]
机构
[1] Maastricht Univ, Dept Internal Med, Med Ctr, Maastricht, Netherlands
[2] Maastricht Univ, Sch Cardiovasc Dis CARIM, Maastricht, Netherlands
[3] Univ Med Ctr Utrecht, Dept Neurol, Brain Ctr Rudolf Magnus, Utrecht, Netherlands
[4] Maastricht Univ, Dept Psychiat & Neuropsychol, Med Ctr, Maastricht, Netherlands
[5] Maastricht Univ, Sch Mental Hlth & Neurosci, Maastricht, Netherlands
[6] Maastricht Univ, Sch Publ Hlth & Primary Care CAPHRI, Maastricht, Netherlands
[7] Maastricht Univ, Dept Epidemiol, Maastricht, Netherlands
关键词
DEMENTIA; RISK; MELLITUS; BRAIN; COMPLICATIONS; IMPAIRMENT; DECLINE; ADULTS; TESTS; HYPERTENSION;
D O I
10.2337/dc17-0330
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVE To study to what extent differences in cognitive performance between individuals with different glucose metabolism status are potentially attributable to hyperglycemia, insulin resistance, and blood pressure-related variables. RESEARCH DESIGN AND METHODS We used cross-sectional data from 2,531 participants from the Maastricht Study (mean +/- age SD, 60 +/- 8 years; 52% men; n = 666 with type 2 diabetes), all of whom completed a neuropsychological test battery. Hyperglycemia was assessed by a composite index of fasting glucose, postload glucose, glycated hemoglobin (HbA(1c)), and tissue advanced glycation end products; insulin resistance by the HOMA of insulin resistance index; and blood pressure-related variables included 24-h ambulatory pressures, their weighted SDs, and the use of antihypertensive medication. Linear regression analyses were used to estimate mediating effects. RESULTS After adjustment for age, sex, and education, individuals with type 2 diabetes, compared with those with normal glucose metabolism, performed worse in all cognitive domains (mean differences in composite z scores for memory -0.087, processing speed -0.196, executive function and attention -0.182; P values <0.032), whereas individuals with prediabetes did not. Diabetes-associated differences in processing speed and executive function and attention were largely explained by hyperglycemia (mediating effect 79.6% [bootstrapped 95% CI 36.6; 123.4] and 50.3% [0.6; 101.2], respectively) and, for processing speed, to a lesser extent by blood pressure-related variables (17.7% [5.6; 30.1]), but not by insulin resistance. None of the factors explained the differences in memory function. CONCLUSIONS Our cross-sectional data suggest that early glycemic and blood pressure control, perhaps even in the prediabetic stage, may be promising therapeutic targets for the prevention of diabetes-associated decrements in cognitive performance.
引用
收藏
页码:1537 / 1547
页数:11
相关论文
共 43 条
[1]   Blood pressure variability and risk of dementia in an elderly cohort, the Three-City Study [J].
Alperovitch, Annick ;
Blachier, Martin ;
Soumare, Aicha ;
Ritchie, Karen ;
Dartigues, Jean-Francois ;
Richard-Harston, Sandrine ;
Tzourio, Christophe .
ALZHEIMERS & DEMENTIA, 2014, 10 (05) :S330-S337
[2]   Insulin in the brain: There and back again [J].
Banks, William A. ;
Owen, Joshua B. ;
Erickson, Michelle A. .
PHARMACOLOGY & THERAPEUTICS, 2012, 136 (01) :82-93
[3]   Tests of Mediation: Paradoxical Decline in Statistical Power as a Function of Mediator Collinearity [J].
Beasley, T. Mark .
JOURNAL OF EXPERIMENTAL EDUCATION, 2014, 82 (03) :283-306
[4]   Dementia and cognitive decline in type 2 diabetes and prediabetic stages: towards targeted interventions [J].
Biessels, Geert Jan ;
Strachan, Mark W. J. ;
Visseren, Frank L. J. ;
Kappelle, L. Jaap ;
Whitmer, Rachel A. .
LANCET DIABETES & ENDOCRINOLOGY, 2014, 2 (03) :246-255
[5]   Risk of dementia in diabetes mellitus: a systematic review [J].
Biessels, GJ ;
Staekenborg, S ;
Brunner, E ;
Brayne, C ;
Scheltens, P .
LANCET NEUROLOGY, 2006, 5 (01) :64-74
[6]   Biochemistry and molecular cell biology of diabetic complications [J].
Brownlee, M .
NATURE, 2001, 414 (6865) :813-820
[7]   Therapies for hyperglycaemia-induced diabetic complications: from animal models to clinical trials [J].
Calcutt, Nigel A. ;
Cooper, Mark E. ;
Kern, Tim S. ;
Schmidt, Ann Marie .
NATURE REVIEWS DRUG DISCOVERY, 2009, 8 (05) :417-429
[8]  
Crane PK, 2013, NEW ENGL J MED, V369, P540, DOI [10.1056/NEJMc1311765, 10.1056/NEJMoa1215740]
[9]  
DeFronzo RA, 2010, DIABETES CARE, V33, P951, DOI [10.2337/dc10-0646, 10.2337/dc09-1521]
[10]   Renal protection in diabetes: Role of glycemic control [J].
Fioretto, Paola ;
Bruseghin, Marino ;
Berto, Ilaria ;
Gallina, Pietro ;
Manzato, Enzo ;
Mussap, Michele .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2006, 17 (04) :S86-S89